Fizazi, et al. ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC). ASCO-GU 2019, abstract 140.
“Een arts op TikTok bereikt jongeren via hun leefwereld”
apr 2024 | Longoncologie
mrt 2024
nov 2023
sep 2023